IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Due to its central role in breaking chains of infection by providing SARS-CoV-2 infection tests, the industry recorded sales growth in 2020 and 2021. While the corona diagnostics sector recorded strong growth, sales development in routine diagnostics stagnated. Since then, industry sales have fallen again - a development that marks the end of the pandemic-related boom. Overall, the industry has shrunk by an average of 2.2% per year over the past five years. Since 2021, the industry's profits have been burdened by cost increases that were not sufficiently covered. For example, expenditure on wages and salaries, energy and transport costs and thus also the expenses for sample logistics and the prices of in-vitro diagnostics manufacturers have risen sharply. The fixed fee scales EBM and GOÄ do not allow the outpatient medical sector to refinance cost increases through price adjustments.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Medical Laboratories industry in Germany includes market sizing, forecasting, data and analysis from 2016-2031. The most recent publication was released February 2026.
The Medical Laboratories industry in Germany operates under the WZ industry code Q86.30DE. The industry specialises in the analysis of body fluids and excretions to diagnose diseases or monitor treatment. Methods from chemistry and biology are used for this purpose. Laboratory medicine is an interdisciplinary field of medicine. Related terms covered in the Medical Laboratories industry in Germany include point-of-care testing, pcr test, uniform valuation standard, diagnosis related groups (drg), medical information objects, kim services and liquid biopsy.
Products and services covered in Medical Laboratories industry in Germany include General laboratory tests, Pathology examinations and Analyses in the field of microbiology.
Companies covered in the Medical Laboratories industry in Germany include Limbach Gruppe SE, Sonic Healthcare Germany GmbH & Co. KG and Amedes Medizinische Dienstleistungen GmbH.
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Medical Laboratories industry in Germany.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
The Products and Markets chapter covers detailed products and service segmentation and analysis of major markets for the for the Medical Laboratories industry in Germany.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Medical Laboratories industry in Germany.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Medical Laboratories industry in Germany. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
The Companies chapter covers Key Takeaways, Market Share and Companies in the Medical Laboratories industry in Germany. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Medical Laboratories industry in Germany. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Medical Laboratories industry in Germany. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Medical Laboratories industry in Germany.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
The market size of the Medical Laboratories industry in Germany is €12.5bn in 2026.
There are 631 businesses in the Medical Laboratories industry in Germany, which has declined at a CAGR of 0.4 % between 2021 and 2026.
The Medical Laboratories industry in Germany is unlikely to be materially impacted by import tariffs with imports accounting for a low share of industry revenue.
The Medical Laboratories industry in Germany is unlikely to be materially impacted by export tariffs with exports accounting for a low share of industry revenue.
The market size of the Medical Laboratories industry in Germany has been declining at a CAGR of 3.7 % between 2021 and 2026.
Over the next five years, the Medical Laboratories industry in Germany is expected to grow.
The biggest companies operating in the Medical Laboratories industry in Germany are Limbach Gruppe SE, Sonic Healthcare Germany GmbH & Co. KG and Amedes Medizinische Dienstleistungen GmbH
General laboratory tests and Pathology examinations are part of the Medical Laboratories industry in Germany.
The company holding the most market share in the Medical Laboratories industry in Germany is Limbach Gruppe SE.
The level of competition is high and increasing in the Medical Laboratories industry in Germany.